Photo: ilgiorno.it
Jun 13, 2025, 09:43
Giuseppe Procopio: Current status of adiuvant immunotherapy in RCC
Giuseppe Procopio, Head of the Genitourinary Unit at Fondazione Istituto Nazionale Tumori, Milan, shared a post on X:
“Current status of adiuvant immunotherapy in RCC: a Delphi study coordinated by Bernard Escudier.”
Title: Current Status of Adjuvant Immunotherapy and Relapse Management in Renal Cell Carcinoma: Insights from a European Delphi study
Authors: Viktor Grünwald, Axel Bex, Sylvie Rottey, Cristina Suárez, Giuseppe Procopio, Guillermo Velasco, Bohuslav Melichar, Jens Bedke, Lisa Pickering, Mário Fontes-Sousa, Manuela Schmidinger, Aristotelis Bamias, Marine Gross-Goupil, Camillo Porta, Philippe Barthélémy, Bernard Escudier, Laurence Albiges
Read the Full Article.
Aristotelis Bamias
Axel Bex
Bernard Escudier
Bohuslav Melichar
Camillo Porta
cancer
Cristina Suárez
Giuseppe Procopio
Guillermo Velasco
immunotherapy
Jens Bedke
Laurence Albiges
Lisa Pickering
Manuela Schmidinger
Marine Gross-Goupil
Mário Fontes-Sousa
OncoDaily
Oncology
Philippe Barthélémy
Sylvie Rottey
Viktor Grünwald
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04
Jul 3, 2025, 09:50